Managing Diarrhea Associated with Glycopyrrolate

Clinical Evaluation and Management

The American College of Physicians recommends assessing patients for signs of intestinal obstruction, including abdominal examination, bowel sounds, and systemic signs, when diarrhea develops during glycopyrrolate therapy 1
The Centers for Disease Control and Prevention suggests evaluating hydration status by examining skin turgor, mucous membranes, mental status, and vital signs, and administering oral rehydration solution (ORS) 50 mL/kg over 2-4 hours for mild dehydration 2, 3
The National Comprehensive Cancer Network recommends obtaining imaging (abdominal X-ray or CT) if obstruction is suspected, and checking complete blood count and electrolytes if patient appears systemically ill 5, 1
The Infectious Diseases Society of America recommends considering stool studies if infectious etiology is suspected, particularly if patient has fever, bloody stools, or recent antibiotic use 2, 4

The American Gastroenterological Association suggests dietary modifications, such as eliminating lactose-containing products and high-osmolar supplements, and recommending BRAT diet (bananas, rice, applesauce, toast), if diarrhea persists after glycopyrrolate discontinuation and obstruction is excluded 2, 6
The American College of Gastroenterology recommends loperamide for adults only (contraindicated in children <18 years), starting 4 mg initially, then 2 mg after each loose stool (maximum 16 mg/day), if diarrhea persists after glycopyrrolate discontinuation and obstruction is excluded 2, 6, 4

The FDA recommends closely monitoring for return of diarrhea, development of constipation or abdominal distention, changes in bowel movement frequency or character, and abdominal pain, nausea, or vomiting, if glycopyrrolate is restarted 4, 2, 1, 2